Inventor

BENNETT C FRANK

US191 patents

⚠️ This page may combine multiple inventors who share the name “BENNETT C FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BENNETT C FRANK

ISIS PHARMACEUTICALS INC

Antisense modulation of CD40 expression

Antisense inhibition of vascular endothelial growth factor receptor-1 expression

Antisense modulation of calreticulin expression

Antisense modulation of lysophospholipase I expression

Antisense modulation of novel anti-apoptotic bcl-2-related proteins

Oligonucleotide modulation of cell adhesion

Compositions and methods for the treatment of severe acute respiratory syndrome (SARS)

Oligonucleotide compositions and methods for the modulation of the expression of B7 protein

Alteration of cellular behavior by antisense modulation of mRNA processing

Antisense modulation of BCL-X expression

Antisense modulation of Ship-2 expression

Antisense modulation of microtubule-associated protein 4 expression

Antisense inhibition of interleukin-15 expression

Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2

Compositions and their uses directed to huntingtin

Antisense modulation of bcl-x expression

Antisense modulation of cell adhesion molecule expression and treatment of cell adhesion molecule-associated diseases

Antisense oligonucleotide modulation of multidrug resistance-associated protein

Antisense modulation of superoxide dismutase 1, soluble expression

Antisense modulation of superoxide dismutase 1, soluble expression

Methods for slowing familial ALS disease progression

Antisense modulation of bcl-x expression

Modulation of telomere length by oligonucleotides having a G-core sequence

Antisense inhibition of src-c expression

Antisense modulation of survivin expression

Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expression

Antisense modulation of CD40 expression

Oligonucleotide compositions and methods for the modulation of the expression of B7 protein

Antisense modulation of NF-kappa-B p65 subunit expression

Antisense modulation of Beta catenin expression

Oligonucleotide inhibition of epidermal growth factor receptor expression

Oligonucleotide modulation of cell adhesion

Modulation of dystrophia myotonica-protein kinase (DMPK) expression

Antisense modulation of superoxide dismutase 1, soluble expression

Enhanced antisense modulation of ICAM-1

Antisense modulation of PECAM-1

Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression

Antisense oligonucleotide modulation of human HER-2 expression

Oligonucleotides having a conserved G4 core sequence

BENNETT C FRANK

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

Method for inhibiting the activity of mir-155

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Compositions and methods for modulation of LMNA expression

Compositions and methods for modulation of SMN2 splicing in a subject

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Chimeric oligomeric compounds for modulation of splicing

REGULUS THERAPEUTICS INC

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

LOLLO BRIDGET

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

IONIS PHARMACEUTICALS INC

Methods for modulating Ataxin 2 expression